Problems associated with pharmacotherapy (in particular, medication errors and adverse
drug events) are frequent and are associated with increased costs for treatment. Analysis of …

OBJECTIVES: In early stage psychosis research the identification of neurobiological correlates
of vulnerability to schizophrenia is an important hurdle. METHODS: We systematically …

Unfortunately, there is no endogenous marker for hepatic clearance that can be used as a
guide for drug dosing. In order to predict the kinetic behaviour of drugs in cirrhotic patients, …

Background/Aims Studies in animals suggest a physiological role for glucagon-like peptide-1-(7–36)-amide
(GLP-1) in regulating satiety. The role of GLP-1 in regulating food intake in …

Importance Sleeve gastrectomy is increasingly used in the treatment of morbid obesity, but
its long-term outcome vs the standard Roux-en-Y gastric bypass procedure is unknown. …

… Furthermore, it is known that intravenously administered GLP-1 retains its blood glucose-lowering
potency during continuous infusion for up to 7 days (J. Larsen, unpublished data). On …

This study evaluated the effect of physiological, TSH-guided, l-thyroxine treatment on serum
lipids and clinical symptoms in patients with subclinical hypothyroidism. Sixty-six women …

Background: The exclusion of the proximal small intestine is thought to play a major role in
the rapid improvement in the metabolic control of diabetes after gastric bypass. Objective: In …

Glucagon-like peptide-1-(7–36)-amide (GLP-1) is involved in satiety control and glucose
homeostasis. Animal studies suggest a physiological role for GLP-1 in water and salt …

Background & Aims: Studies in animals and humans suggest a role for peptide YY (PYY 3–36
) in regulating satiety. The physiologic role of PYY 3–36 , however, has not been …